JOURNAL OF BUON, cilt.18, sa.2, ss.377-384, 2013 (SCI-Expanded)
Purpose: To retrospectively assess the efficacy and toxity of a modified docetaxel, cisplatin, fluorouracil (mDCF) regimen as primary treatment in patients with metastatic gastric cancer (MGC).